Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

OptiCept Technologies

2,80 SEK

-12,09 %

Mindre end 1K følgere

OPTI

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
Sammenligne
-12,09 %
-26,32 %
-44,22 %
-31,71 %
-43,55 %
-42,68 %
-78,09 %
-92,55 %
-44,47 %

OptiCept Technologies provides the food and plant industry with technological solutions that are used to increase the sustainability of various raw materials. The company works with biological processes that provide increased extraction from the raw material, reduced waste and maintained taste, aroma, color, nutritional content. The company has a patented technology within PEF (pulsed electric field) and VI (Vacuum Infusion). The company sells its products on a global level. The headquarters are located in Lund.

Læs mere
Markedsværdi
182,41 mio. SEK
Aktieomsætning
1,18 mio. SEK
Omsætning
17,67 mio.
EBIT %
-317,43 %
P/E
-
Udbytteafkast, %
-
Seneste analyse

Seneste analyse

Udgivelse: 02.12.2024

Seneste omfattende analyse

Udgivelse: 02.02.2024

Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
18.12
2025

Ekstraordinær generalforsamling '25

27.2
2026

Årsrapport '25

21.5
2026

Generalforsamling '26

Alle
Analyse
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper
Selskabsmeddelelse1.12.2025, 14.30

Notice of Extraordinary General Meeting in OptiCept Technologies AB (publ)

OptiCept Technologies
Selskabsmeddelelse26.11.2025, 17.15

Correction: OptiCept Technologies Interim Report Q3 2025

OptiCept Technologies
Pressemeddelelse24.11.2025, 08.00

Strong quarter and new financing show the path to positive EBITDA for the full year 2026

OptiCept Technologies

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Pressemeddelelse24.11.2025, 06.58

DNB Carnegie Access: OptiCept Technologies: Cash flow conversion concerning, raises debt – Q3 review

OptiCept Technologies
Selskabsmeddelelse23.11.2025, 19.55

OptiCept refinances loan of approx. SEK 21.4 million, receives additional liquidity through a new loan of approx. SEK 17.5 million, and enters into a credit facility of SEK 10 million

OptiCept Technologies
Selskabsmeddelelse21.11.2025, 16.35

OptiCept Technologies Interim Report Q3 2025

OptiCept Technologies
Pressemeddelelse3.11.2025, 15.57

DNB Carnegie Access: OptiCept Technologies: Deliveries on H1 order intake to commence – Q3 preview

OptiCept Technologies
Selskabsmeddelelse21.10.2025, 08.35

OptiCept Technologies AB announces Nomination Committee ahead of the 2026 Annual General Meeting

OptiCept Technologies
Pressemeddelelse25.9.2025, 07.45

OptiCept Receives New Order from Juice Producer in Costa Rica

OptiCept Technologies
Pressemeddelelse24.9.2025, 06.50

OptiCept reduces its production costs by 40%

OptiCept Technologies
Pressemeddelelse12.9.2025, 06.35

OptiCept launches system for larger volumes

OptiCept Technologies
Pressemeddelelse4.9.2025, 06.44

OptiCept Expands Production Capacity of CEPT® Systems

OptiCept Technologies
Pressemeddelelse29.8.2025, 09.35

DNB Carnegie Access: Opticept: Intervju - Rapportintervju

OptiCept Technologies
Pressemeddelelse28.8.2025, 16.13

DNB Carnegie Access: OptiCept Technologies: Encouraging order intake, eyes on cash flow – Q2 review

OptiCept Technologies
Pressemeddelelse28.8.2025, 07.54

DNB Carnegie Access: OptiCept Technologies: Financials as we expected, strong order intake – Q2 initial

OptiCept Technologies
Selskabsmeddelelse28.8.2025, 06.55

Correction: OptiCept Technologies Interim Report Q2 2025

OptiCept Technologies
Selskabsmeddelelse28.8.2025, 06.00

OptiCept Technologies Interim Report Q1 2025

OptiCept Technologies
Pressemeddelelse15.8.2025, 07.15

OptiCept Technologies AB changes Certified Adviser to Tapper Partners AB

OptiCept Technologies
Pressemeddelelse14.8.2025, 06.30

New Patent Strengthens OptiCept Technologies’ Market Position

OptiCept Technologies
Pressemeddelelse13.8.2025, 13.32

DNB Carnegie Access: OptiCept Technologies: Order intake accelerating at a crucial time – Q2 preview

OptiCept Technologies
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.